Join us   Log in  

PHARMASPIRE - Volume 11, Issue 3, July - September, 2019

Pages: 69-75

Date of Publication: 14-Jun-2022

Print Article   Download XML  Download PDF

Nanoparticles as carrier for oral drug delivery system

Author: Harmandeep Kaur, Amandeep Singh, Karishma Aggarwal

Category: Pharmaceutics


Due to the non-targeted drug delivery systems, various types of side effects are observed, in case of nanoparticle (NP), it acts as boom form the management of various diseases, with negligible side effects with maximum bioavailability of the drugs. However, many biological therapeutics that have poor solubility, poor permeability, or poor stability in the gastrointestinal environment include poor oral bioavailability and are consequently rarely used for oral drug delivery. Oral route is most frequent used method for drug delivery. In this paper, we have tried to cover the various nanocarriers for oral drug delivery system also brief about the challenge in drug delivery system such as dendrimers, liposomes, solid lipid nanocarriers, micelles, and polymeric NPs. These nanocarriers have been tailored as per the need of the disease for obtaining cellular level such as pH and presence of enzymes. The advantages of novel drug delivery carrier system over conventional drugs have been discussed, last discussed about Food and Drug Administration approved medicine as nanocarrier.

Keywords: Oral drug delivery system, novel drug delivery system, control release, sustained release


1. Verma RK, Garg S. Drug delivery technologies and future directions. Pharm Technol 2001;25:1-4.

2. Sharma M, Sharma R, Jain DK. Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Scientifica 2016;2016:8525679.

3. Delmar K, Bianco-Peled H. Composite chitosan hydrogels for extended release of hydrophobic drugs. Carbohydr Polym 2016;136:570-80.

4. Gupta H, Bhandari D, Sharma A. Recent trends in oral drug delivery: A review. Recent Pat Drug Deliv Formul 2009;3:162-73.

5. Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2007;2:17-71.

6. Roco MC, Bainbridge WS. Societal implications of nano science and nanotechnology: Maximizing human benefit. J Nanopart Res 2005;7:1-3.

7. Khan MG, Chandel HS. Organic nitrogenous compound involved in local immune responses. World J Pharm Pharm Sci 2017;6:434-41.

8. Khalid M, El-Sawy HS. Polymeric nanoparticles: Promising platform for drug delivery. Int J Pharm 2017;528:675-91.

9. Vasile C. Polymeric Nanomaterials in Nanotherapeutics. Netherlands: Elsevier; 2018.

10. Renn O, Roco MC. Nanotechnology and the need for risk governance. J Nanopart Res 2006;8:153-91.

11. Colombo M, Carregal-Romero S, Casula MF, Gutiérrez L, Morales MP, Böhm IB, et al. Biological applications of magnetic nanoparticles. Chem Soc Rev 2012;41:4306-34.

12. Malik MA, Wani MY, Hashim MA. Microemulsion method: A novel route to synthesize organic and inorganic nanomaterials: 1st nano update. Arab J Chem 2012;5:397-417.

13. Epifani M, Giannini C, Tapfer L, Vasanelli L. Sol-gel synthesis and characterization of Ag and Au nanoparticles in SiO2, TiO2, and ZrO2 thin films. J Am Ceram Soc 2000;83:2385-93.

14. Zhang F, Yan Y, Yang H, Meng Y, Yu C, Tu B, et al. Understanding effect of wall structure on the hydrothermal stability of mesostructured silica SBA-15. J Phys Chem B 2005;109:8723-32.

15. Gupta N, Singh HP, Sharma RK. Metal nanoparticles with high catalytic activity in degradation of methyl orange: An electron relay effect. J Mol Catal A Chem 2011;335:248-52.

16. Yadav A, Ghune M, Jain DK. Nano-medicine based drug delivery system. J Adv Pharm Educ Res 2011;1:201-13.

17. Dadhich A. Future effect of nano-medicine on human generation. Int J Eng 2012;2:7-11.

18. Chetty CM. Nanomedicine and drug delivery-revolution in health system. J Glob Trends Pharm Sci 2011;2:21-30.

19. Singh A, Kaur K, Kaur V, Singh G, Mandal UK, Mishra N, et al. Importance of nanocarriers and probiotics in the treatment of ulcerative colitis. J Drug Deliv Ther 2019;9:216-28.

20. Zhang XQ, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Deliv Rev 2012;64:1363-84.

21. Staples M, Daniel K, Cima MJ, Langer R. Application of micro-and nanoelectromechanical devices to drug delivery. Pharm Res 2006;23:847-63.

22. Palombo M, Deshmukh M, Myers D, Gao J, Szekely Z, Sinko PJ. Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery. Annu Rev Toxicol 2014;54:581-98.

23. Samad A, Alam MI, Saxena K. Dendrimers: A class of polymers in the nanotechnology for the delivery of active pharmaceuticals. Curr Pharm Design 2009;15:2958-69.

24. Esim O, Kurbanoglu S, Savaser A, Ozkan SA, Ozkan Y. Nanomaterials for drug delivery systems. In: New Developments in Nanosensors for Pharmaceutical Analysis. United States: Academic Press Inc.; 2019. p. 273-301.

25. Sharma G, Anabousi S, Ehrhardt C, Kumar MN. Liposomes as targeted drug delivery systems in the treatment of breast cancer. J Drug Target 2006;14:301-10.

26. Ochekpe NA, Olorunfemi PO, Ngwuluka NC. Nanotechnology and drug delivery part 2: Nanostructures for drug delivery. Trop J Pharm Res 2009;8:278.

27. Khan AA, Mudassir J, Mohtar N, Darwis Y. Advanced drug delivery to the lymphatic system: Lipid-based nanoformulations. Int J Nanomed 2013;8:2733.

28. Singh A, Rath G, Singh R, Goyal AK. Nanofibers: An effective tool for controlled and sustained drug delivery. Curr Drug Deliv 2018;15:155-66.

29. Narain R. Engineered Carbohydrate-based Materials for Biomedical Applications: Polymers, Surfaces, Dendrimers, Nanoparticles, and Hydrogels. United States: John Wiley & Sons; 2011.

30. Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 2004;61:2549-59.

31. Silva GA, Ducheyne P, Reis RL. Materials in particulate form for tissue engineering. 1. Basic concepts. J Tissue Eng Regen Med 2007;1:4-24.

32. Grottkau BV, Cai X, Wang J, Yang X, Lin Y. Polymeric nanoparticles for a drug delivery system. Curr Drug Metab 2013;14:840-6.

33. Durfee PN, Lin YS, Dunphy DR, Mun?iz AJ, Butler KS, Humphrey KR, et al. Mesoporous silica nanoparticle-supported lipid bilayers (protocells) for active targeting and delivery to individual leukemia cells. ACS Nano 2016;10:8325-45.

34. Bagheri E, Ansari L, Abnous K, Taghdisi SM, Charbgoo F, Ramezani M, et al. Silica based hybrid materials for drug delivery and bioimaging. J Contro Release 2018;277:57-76.

35. Dienerowitz M, Mazilu M, Reece PJ, Krauss TF, Dholakia K. Optical vortex trap for resonant confinement of metal nanoparticles. Opt Express 2008;16:4991-9.

36. Chaughule RS, Purushotham S, Ramanujan RV. Magnetic nanoparticles as contrast agents for magnetic resonance imaging. Proc Natl Acad Sci India A Phys Sci 2012;82:257-68.

37. Lu Z, Prouty MD, Guo Z, Golub VO, Kumar CS, Lvov YM. Magnetic switch of permeability for polyelectrolyte microcapsules embedded with Co@ Au nanoparticles. Langmuir 2005;21:2042-50.

38. Vollath D, Szabo DV, Hauβelt J. Synthesis and properties of ceramic nanoparticles and nanocomposites. J Eur Ceram Soc 1997;17:1317-24.

39. Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, Fu T, et al. Nanotechnology in therapeutics: A focus on nanoparticles as a drug delivery system. Nanomedicine 2012;7:1253-71.

40. Pissuwan D, Niidome T, Cortie MB. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release 2011;149:65-71.

41. Inagaki M, Kang F, Toyoda M, Konno H. Advanced Materials Science and Engineering of Carbon. United Kingdom: Butterworth-Heinemann; 2013.

42. Rawashdeh RY. Mechanistic Studies of Water Soluble Fullerenes as Free Radical Scavengers, Biological Antioxidants and NF-kappaB Inhibitors. North Carolina: The University of North Carolina at Greensboro; 2014.

43. Adzhri R, Arshad MM, Gopinath SC, Ruslinda AR, Fathil MF, Ayub RM, et al. High-performance integrated field-effect transistor-based sensors. Anal Chim Acta 2016;917:1-8.

44. Baddour CE, Briens C. Carbon nanotube synthesis: A review. Int J Chem React Eng 2005;3:1-20.

45. Muniandy S, Teh SJ, Thong KL, Thiha A, Dinshaw IJ, Lai CW, et al. Carbon nanomaterial-based electrochemical biosensors for foodborne bacterial detection. Crit Rev Anal Chem 2019;49:510-33.